International Fellowship for the study of Soft Tissue Sarcoma
- 2024 Application

The Murray F. Brennan International Fellowship for the study of Soft Tissue Sarcoma in Low and Middle-Income Countries

Memorial Sloan Kettering Cancer Centers’ Global Cancer Disparities Initiatives (GCDI) Program and the African Research Group for Oncology (ARGO) announce the Murray F. Brennan International Fellowship for the study of Soft Tissue Sarcoma in Low and Middle-Income Countries. The incidence and outcomes for soft tissue sarcomas (STS) are unknown in low- and middle-income countries. Global cancer models do not have the data needed to even provide estimates. This fellowship aims to fill this gap by providing data to aid cancer clinicians, researchers, and policymakers with data that will increase knowledge of STS and how to improve outcomes for patients with these cancers.

Duration: One Year

Program Structure: Fellows will spend three months at MSK to train in data collection, bioinformatics, and pathology collection with MSK faculty. The fellowship will link with STS subspecialists at MSK. After the initial MSK training period, there will be nine months in Nigeria working with ARGO and MSK staff to generate data for STS-focused research projects. This will begin with developing a multi-institutional clinical and pathologic database for STS. ARGO resources include MOTIC scanners that can allow for remote digital pathology training with MSK STS pathology experts. 

Anticipated start date: Fall/Winter 2024

Eligibility Criteria:

 Open to all physicians who treat or study sarcoma patients, including Surgeons, Pathologists, Radiologists, Radiation or Clinical Oncologists, and Epidemiologists, who aim for a career in cancer research.
 Holds a faculty position at a Nigerian institution.
 Support from home institution ensuring leave from their faculty position and support for protected research time.
 Confirmation that an academic job is available to the applicant on return to Nigeria
 Applicants will be required to provide three letters of support.

Applications must be received by 17 May 2024